Home

Andrew Cheng, President and CEO: Akero Therapeutics AKRO Sell · Filed 25/06/12

Trade details

Type
Insider sale
Amount
$823,837.3
Shares · price
15,158 sh · $54.35 a share
Held after
564,324 sh
Trade date
25/06/10
Filed
25/06/12
Days to filing
2 days

Sold 2.6% of holdings

Share of holding sold
2.6%

Akero Therapeutics trades, last 26 weeks

What else happened in Akero Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/11~25/07/10

Andrew Cheng's recent trades

  • Andrew Cheng

    Sell10b5-1 planAkero Therapeutics

    $1.6M

    Filed 25/10/14

  • Andrew Cheng

    Sell10b5-1 planAkero Therapeutics

    $968.3K

    Filed 25/09/12

  • Andrew Cheng

    Sell10b5-1 planAkero Therapeutics

    $321.9K

    Filed 25/09/12

  • Andrew Cheng

    Sell10b5-1 planAkero Therapeutics

    $77.3K

    Filed 25/09/12

  • Andrew Cheng

    Sell10b5-1 planAkero Therapeutics

    $7,050

    Filed 25/09/12

Andrew Cheng, CEO — sold $823.8K of Akero Therapeutics AKRO · 2.6% of holdings · 10b5-1 plan | Whalegun